Diabetes Has a Golden Window, Too: Starting Treatment Within 3 Months Cuts Death Risk 69%
It is easy to assume that people with type 2 diabetes do not need to rush into treatment. Most patients have no serious symptoms in the early stages,...
Search results for "diabetes drug"
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour
Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s obesity drug candidate "EPPE" has...
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
Taking Leqembi Isn’t Enough: Only 3% of Early Alzheimer’s Patients Follow Recommended Lifestyle Habits
The arrival of disease-modifying treatments capable of slowing Alzheimer’s progression has offered patients newfound...
JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide
JW Pharmaceutical announced on Aug. 18 that it has submitted an Investigational New Drug application to South Korea’s...
South Korea to Deploy AI Across Public Health Centers and Ambulances to Close Care Gaps
Artificial intelligence tools that assist in interpreting X-ray images and drafting clinical notes will soon be...
As the U.S. Reconsiders Direct-to-Consumer Drug Ads, What Lessons Should We Learn?
During a yearlong stay in the United States, one of the things that struck me most was how easy it is to come across...
10 Reasons Grapes Are Good for You—Even If You Have Diabetes
A single grape may be small, but it packs a powerful nutritional punch. Rich in essential vitamins, minerals, and...
Yuri's Secret to Staying Slim: Why This Jeju Seaweed Keeps You Full and Blunts Blood Sugar Spikes
Girls' Generation member and actor Yuri, 36, recently showcased her healthy eating habits, giving fans a glimpse into...
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven
Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.